Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient
Dermatol Ther
.
2020 Jul;33(4):e13668.
doi: 10.1111/dth.13668.
Epub 2020 Jun 24.
Authors
Olga Yu Olisova
1
,
Ekaterina M Anpilogova
1
,
Dariya A Svistunova
1
Affiliation
1
Dermatology Department, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
PMID:
32449265
PMCID:
PMC7267080
DOI:
10.1111/dth.13668
No abstract available
Publication types
Letter
Comment
MeSH terms
Arthritis, Psoriatic*
Betacoronavirus
COVID-19
Coronavirus Infections*
Critical Care
Humans
Infections*
Oligodendroglioma*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Thalidomide / analogs & derivatives
Substances
Thalidomide
apremilast